ClinicalTrials.Veeva

Menu

Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study

The Ohio State University logo

The Ohio State University

Status

Completed

Conditions

Breast Carcinoma

Treatments

Other: Non-Interventional Study

Study type

Observational

Funder types

Other

Identifiers

NCT06205394
OSU-22123 (Other Identifier)
NCI-2023-00667 (Registry Identifier)

Details and patient eligibility

About

This study evaluates Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority (INTENDED for SGM) in identifying the patient, support person and provider barriers to quality care in SGM breast/chest cancer survivors.

Full description

PRIMARY OBJECTIVE:

I. To determine the important ways the iCanDecide breast cancer decision aid needs revised for SGM people, and how best to integrate a culturally-relevant tool into clinical practice.

OUTLINE: This is an observational study.

AIM 1: Interview transcripts from SANGRIA study utilized to explore the values, preferences and key considerations for breast cancer treatment decision making in SGM individuals.

AIM 2: Patients are assigned to 1 of 2 groups.

GROUP 1: Cancer survivors participate in a focus group on study.

GROUP 2: Breast cancer clinicians undergo a semi-structured interview on study.

Enrollment

28 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • SURVIVORS:

    • Self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender
    • Must be a breast cancer survivor, in active treatment or completed active treatment in the last 10 years (not including hormone therapy)
    • Be over age 18
    • English-speaking
    • Received care in the US

BREAST ONCOLOGY CLINICIANS: Physicians, advanced practice providers, nurses, psychologists and social workers will be eligible if they:

  • Provide care and/or surgical decision support to individuals diagnosed with early stage breast cancer in the US
  • Are English-speaking

Trial design

28 participants in 2 patient groups

GROUP 1 (focus group)
Description:
Cancer survivors participate in a focus group on study.
Treatment:
Other: Non-Interventional Study
GROUP 2 (interview)
Description:
Breast cancer clinicians undergo a semi-structured interview on study.
Treatment:
Other: Non-Interventional Study

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems